BETR — BetterLife Pharma Balance Sheet
0.000.00%
- CA$24.27m
- CA$28.37m
Annual balance sheet for BetterLife Pharma, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.174 | 0.008 | 0.037 | 0.008 | 0.013 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.325 | 0.017 | 0.04 | 0.012 | 0.003 |
| Prepaid Expenses | |||||
| Total Current Assets | 1.14 | 0.075 | 0.325 | 0.225 | 0.22 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.018 | 0 | — | — | — |
| Net Intangible Assets | |||||
| Total Assets | 1.16 | 0.075 | 0.325 | 0.225 | 0.22 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.14 | 7.15 | 6.83 | 7.54 | 6.68 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.04 | 10.8 | 11.1 | 10.9 | 10 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -3.88 | -10.7 | -10.8 | -10.7 | -9.78 |
| Total Liabilities & Shareholders' Equity | 1.16 | 0.075 | 0.325 | 0.225 | 0.22 |
| Total Common Shares Outstanding |